Clinical management of arrhythmogenic right ventricular cardiomyopathy: An update

Current Pharmaceutical Design

Volumn 16, Issue 26, 2010, Pages 2918-2928

  Migliore, Federico ^a   Zorzi, Alessandro ^a   Silvano, Maria ^a   Rigato, Ilaria ^a   Basso, Cristina ^b   Thiene, Gaetano ^b   Corrado, Domenico ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiarrhythmic drug therapy; Cardiomyopathy; Catheter ablation; Implantable defibrillator (ICD); Sudden cardiac death; Ventricular arrhythmias

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

ARRYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY; ARTICLE; ATHLETE; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FATALITY; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPORT; SYNCOPE; SYSTOLIC DYSFUNCTION; THROMBOEMBOLISM; TREATMENT INDICATION;

EID: 78649956163     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793176491     Document Type: Article

References (48)

1. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000; 83: 588-95.
2. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373: 1289-300.
3. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricu-lar cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-33.
4. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente ML. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996; 94: 983-91.
5. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997; 30: 1512-20.
6. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: an update. Heart 2009; 95: 766-73.
7. Blomstrom-Lundqvist C, Beckman-Suurkula M, Wallentin I, Jonsson R, Olsson SB. Ventricular dimensions and wall motion assessed by echocardiography in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J 1988; 9: 1291-302.
8. Menghetti L, Basso C, Nava A, Angelini A, Thiene G. Spin-echo nuclear magnetic resonance for tissue characterization in arrhythmogenic right ventricular cardiomyopathy. Heart 1996; 76: 467-70.
9. Daliento L, Rizzoli G, Thiene G, et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 1990; 66: 741-5.
10. Angelini A, Basso C, Nava A, Thiene G. Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. Am Heart J 1996; 132: 203-6.
11. Basso C, Ronco F, Marcus F, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J 2008; 29: 2760-7.
12. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 98-103.
13. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 2008; 51: 731-9.
14. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994; 71: 215-8.
15. Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of relativesfor familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnosticcriteria. J Am Coll Cardiol 2002; 40: 1445-50.
16. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J 2010; 31(7): 806-14.
17. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355: 2119-24.
18. Rampazzo A, Nava A, Danieli GA, et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 1994; 3: 959-62.
19. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004; 36: 1162-64.
20. Pilichou K, Nava A, Basso C, et al. Mutations in Desmoglein-2 gene are associated to arrhythmogenic right ventricular cardiomyopathy. Circulation 2006; 113(9): 1171-9.
21. Syrris P, Ward D, Evans A, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 2006; 79: 978-84.
22. Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006; 113: 1634-7.
23. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000; 36: 2226-33.
24. Marcus F, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Milan: Springer 2007.
25. Buja G, Estes NA 3rd, Wichter T, Corrado D, Marcus F, Thiene G.Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy. Prog Cardiovasc Dis 2008; 50: 282.
26. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003; 108: 3084-91.
27. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004; 109: 1503-8.
28. Roguin A, Bomma CS, Nasir K, et al. Implantable cardioverter defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004; 43: 1843-52.
29. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithsardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37.
30. Wichter T, Paul M, Eckardt L, et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?. Herz 2005; 30: 91-101.
31. Marcus GM, Glidden DV, Polonsky B, et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2009; 54: 609-15.
32. Boulos M, Lashevsky I, Reisner S, Gepstein L. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 2001; 38: 2020-7.
33. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2005; 111: 3042-50.
34. Reithmann C, Hahnefeld A, Remp T, et al. Electroanatomic mapping of endocardial right ventricular activation as a guide for catheter ablation in patients with arrhythmogenic right ventricular dysplasia. PACE 2003; 26: 1308-16.
35. Marchlinski FE, Zado E, Dixit S, et al. Electroanatomical substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 2004; 110: 2293-8.
36. Arbelo E, Josephson ME. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2010; 21: 473-486.
37. Zou J, Cao K, Yang B, et al. Dynamic substrate mapping and ablation of ventricular tachycardias in right ventricular dysplasia. J Interv Card Electrophysiol 2004; 11: 37-45.
38. Fontaine G, Frank R, Rougier I, et al. Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenmic right ventricular dysplasia: experience of 13 patients with a mean follow-up of 45 months. Eur Heart J 1989; 10 (Suppl D): 74-81.
39. Fontaine G, Tonet J, Gallais Y, et al. Ventricular tachycardia ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience Curr Cardiol Rep 2000; 2: 498-506.
40. Ellison KE, Friedman PL, Ganz LI, Stevenson WG. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 1998; 32: 724-8.
41. Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 2005; 111: 3209-16.
42. Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007; 50: 432-40.
43. Breithardt G, Wichter T, Haverkamp W, et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994; 127: 1151-8.
44. Link M, Wang PJ, Haugh CJ, et al. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillator. J Intervent Card Electrophysiol 1997; 1: 41-8.
45. Tavernier R, Gevaert S, De Sutter J, et al. Long term results of cardioverter defibrillator in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001; 85: 53-6.
46. Hodgkinson KA, Parfrey PS, Basset AS, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Am Coll Cardiol 2005; 45: 400-8.
47. Corrado D, Basso C, Pillichou K, Thiene G. Molecular biology and the clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 2010; (in press).
48. Corrado D, Calkins H, Link MS, et al. Prophylactic implantable defibrillator in patients with arrhythromogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010; (in press).